Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients

NCT00564408 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2009-08-03

No results posted yet for this study

Summary

The purpose of this study is to test if carbachol infusion induces headache in migraine subjects as well as intra- and extra-cerebral vasodilatation.

Conditions

Interventions

DRUG

Carbachol

3 microgram per kg bodyweight infused intravenously

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Henrik Schytz, MD · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-10-31
Completion
2009-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00564408 on ClinicalTrials.gov